KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) – July 05, 2023

KalVista Pharmaceuticals, Inc., announced that the compensation committee of KalVista’s board of directors granted two newly-hired employees inducement options to purchase an aggregate of 13,000 shares of KalVista common stock on July 3, 2023 as inducements material to each employee entering into employment with KalVista.

Scroll to Top